Skip to content

Mindfulness trials in cancer report lower distress, with substantial variation

A review found lower depression, anxiety and stress scores with mindfulness programs, but breast cancer trials dominated the evidence.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Across randomized trials in adults with cancer, mindfulness programs were linked to lower depression, anxiety and stress scores than control conditions. The findings concern psychological symptoms. High variation between studies and the concentration of evidence in breast cancer limit confidence about how well the average results apply to other cancer populations.

Keep in mind

The abstract reports high variation between studies and omits confidence intervals, control details and follow-up durations. It cannot establish how durable the symptom changes were or which format works best.

THE NUMBERS, WITH CONTEXT

What researchers found

-0.92 standard deviations

Depression symptoms; Hedges' g

The negative value means lower depression scores with mindfulness programs than control conditions. Assessment timing and a confidence interval were not reported.

Psychooncology, 2026 · Original source ↓

What the effect measures

Hedges' g describes a difference relative to variation in symptom scores, expressed in standard deviations. The depression estimate favors mindfulness programs; it does not measure recovery rates or a percentage reduction in symptoms.

Why subgroup rankings need care

The researchers explored results by program format, cancer type and geographic region. Differences between those subgroups describe patterns within the review; they do not establish that an adapted program is superior in a direct comparison.

CHECK THE ORIGINAL

The original publication

Mindfulness-Based Interventions for Depression, Anxiety, and Stress in Adults With Cancer: A Stratified Subgroup Meta-Analysis.

Ajele KW, Idemudia ES
Psychooncology · 2026

PubMed ID
41820814
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.